Association of hormonal contraception and HIV-seroprevalence in Nairobi, Kenya

AIDS. 2003 Dec 5;17(18):2667-9. doi: 10.1097/00002030-200312050-00016.

Abstract

Among women attending family planning clinics in Nairobi, Kenya, the HIV-seroprevalence rates for different contraceptive methods were: depomedroxyprogesterone acetate (DMPA) 431/3279 (13.1%), combination oral contraceptive pill 114/1073 (10.6%), and progesterone-only contraceptive pill (POCP) 45/741 (6.1%). After adjusting for age, marital status, and parity, women using the POCP had a lower HIV seroprevalence (adjusted odds ratio 0.5, 95% confidence interval 0.3-0.7) than women using DMPA. This association was most pronounced among POCP users of lower parity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • CD4 Lymphocyte Count
  • Contraceptives, Oral, Combined / therapeutic use
  • Contraceptives, Oral, Hormonal / therapeutic use*
  • Disease Susceptibility
  • Female
  • HIV Seropositivity / epidemiology*
  • Humans
  • Kenya / epidemiology
  • Medroxyprogesterone Acetate / therapeutic use
  • Parity
  • Progesterone / therapeutic use*
  • Seroepidemiologic Studies

Substances

  • Contraceptives, Oral, Combined
  • Contraceptives, Oral, Hormonal
  • Progesterone
  • Medroxyprogesterone Acetate